21/05/2013 02:16:17 Free Membership Login
NO^HBWO
   

   

Aspreva

Visual Financials
Company Name: Aspreva Pharmaceuticals Corporation
Ticker Symbol: ASPV
WWW Address: www.aspreva.com
CEO: Dr.J. William Freytag, Ph.D.
No. of Employees: 133
Common Issue Type: CS
Business Description:An emerging global pharmaceutical company focused on identifying, developing, and upon approval, commercializing existing approved drugs and drug candidates for new indications.

 
Industry Information: DRUGS - Biotechnology [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
  Unchanged     26.02 25.98 
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 0.0 35.2 0.29 3.49 0.00 7.4 0.0 26.05 - 15.73
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close26.01$
PE Ratio - LTM7.4
Market Capitalisation0.0mil
Latest Shares Outstanding35.2mil
Earnings pS (EPS)3.49$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee1,614,917$
Effective Tax Rate10.6%
Float31.9mil
Float as % of Shares Outstanding90.6%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue26.10%
Research & Devlopment (R&D) as % of Revenue21.20%
Gross Profit Margin0.0%
EBITDA Margin54.4%
Pre-Tax Profit Margin58.7%
Assets Turnover0.7%
Return on Assets (ROA)28.5%
Return on Equity (ROE)32.2%
Return on Capital Invested (ROCI)32.1%
Current Ratio9.0
Leverage Ratio (Assets/Equity)1.1
Interest Cover8732.9
Total Debt/Equity (Gearing Ratio)0.00
LT Debt/Total Capital0.0%
Working Capital pS10.80$
Cash pS0.79$
Book-Value pS10.94$
Tangible Book-Value pS10.94$
Cash Flow pS3.63$
Free Cash Flow pS3.52$
KEY FIGURES (LTM): Price info
Price/Book Ratio2.38
Price/Tangible Book Ratio2.38
Price/Cash Flow7.2
Price/Free Cash Flow7.4
P/E as % of Industry Group8.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---0.01001,711
4 Weeks26.0525.7625.810.81041,74924,486
13 Weeks26.0521.9022.5015.61275,794336,074
26 Weeks26.0515.7320.1828.91414,703573,736
52 Weeks26.0515.7320.1329.21313,973981,264
YTD26.0525.97-0.01042,0758,298
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
26.0225.9725.6821.7521.600.290.29
 
GROWTH RATES5-Year
Growh		R² of 5-Year Growth3-Year
Growth
Revenue0.000.00.00
Income0.000.00.00
Dividend0.000.00.00
Capital Spending0.00NA210.95
R&D0.00NA106.87
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD		Curr Qtr vs.
Qtr 1-Yr ago		Annual vs.
Last Annual
Revenue %14.230.0180.8
Earnings %-0.2-8.2531.3
EPS %0.4-8.5462.9
EPS $0.01-0.062.87
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio84.63
Current Ratio7.3
Quick Ratio (Acid Test)7.2
Liquidity Ratio (Cash)5.91
Receivables Turnover4.1
Average Collection Period88
Working Capital/Equity98.3
Working Capital pS7.87
Cash-Flow pS3.55
Free Cash-Flow pS4.06
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio15.75
Financial Leverage Ratio (Assets/Equity)1.2
Debt Ratio13.9
Total Debt/Equity (Gearing Ratio)0.00
LT Debt/Equity0.00
LT Debt/Capital Invested0.5
LT Debt/Total Liabilities0.2
Interest Cover3471.6
Interest/Capital Invested0.01
 
VALUATION RATIOS
MULTIPLES
PQ Ratio4.57
Tobin's Q Ratio2.80
Current P/E Ratio - LTM7.40
Enterprise Value (EV)/EBITDA5.45
Enterprise Value (EV)/Free Cash Flow6.10
Dividend Yield0.0
Price/Tangible Book Ratio - LTM2.38
Price/Book Ratio - LTM2.38
Price/Cash Flow Ratio7.2
Price/Free Cash Flow Ratio - LTM7.4
Price/Sales Ratio3.85
P/E Ratio (1 month ago) - LTM7.3
P/E Ratio (26 weeks ago) - LTM6.2
P/E Ratio (52 weeks ago) - LTM5.7
5-Y High P/E Ratio0.0
5-Y Low P/E Ratio0.0
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E
P/E as % of Industry Group8.0
P/E as % of Sector Segment0.0
Current 12 Month Normalized P/E Ratio - LTM7.4
PER SHARE FIGURES
LT Debt pS0.00
Current Liabilities pS1.25
Tangible Book Value pS - LTM10.94
Book Value pS - LTM10.94
Capital Invested pS8.00
Cash pS - LTM0.79
Cash Flow pS - LTM3.63
Free Cash Flow pS - LTM3.52
Earnings pS (EPS)3.49
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin66.47
Free Cash Flow Margin 5YEAR AVG11.52
Net Profit Margin57.8
Net Profit Margin - 5YEAR AVRG.49.4
Equity Productivity0.76
Return on Equity (ROE)44.1
Return on Equity (ROE) - 5YEAR AVRG.0.0
Capital Invested Productivity0.76
Return on Capital Invested (ROCI)44.1
Return on Capital Invested (ROCI) - 5YEAR AVRG.0.0
Assets Productivity0.90
Return on Assets (ROA)38.0
Return on Assets (ROA) - 5YEAR AVRG.0.0
Gross Profit Margin0.0
Gross Profit Margin - 5YEAR AVRG.0.0
EBITDA Margin - LTM54.4
EBIT Margin - LTM58.8
Pre-Tax Profit Margin64.6
Pre-Tax Profit Margin - 5YEAR AVRG.0.0
Effective Tax Rate10.6
Effective Tax Rate - 5YEAR AVRG.2.6
EFFICIENCY RATIOS
Cash Conversion Cycle96
Revenue per Employee1,614,917
Net Income per Employee933,504
Average Collection Period96
Receivables Turnover4.1
Day's Inventory Turnover Ratio
Inventory Turnover0.0
Inventory/Sales0.0
Accounts Payble/Sales6.65
Assets/Revenue1.11
Net Working Capital Turnover0.78
Fixed Assets Turnover34.81
Total Assets Turnover0.9
Revenue per $ Cash4.36
Revenue per $ Plant45.35
Revenue per $ Common Equity0.76
Revenue per $ Capital Invested0.76
Selling, General & Adm/tive (SG&A) as % of Revenue18.1
SG&A Expense as % of Revenue - 5YEAR AVRG.0.0
Research & Devlopment (R&D) as % of Revenue22.3
R&D Expense as % of Revenue - 5YEAR AVRG.22.3

  


NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's

1 site:2 us nasdaq aspv130521 02:16